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ABSTRACT
Introduction. In the current edition, Nastasovic et al. present the results of a prospective study on patients with aneurysm sub-
arachnoid haemorrhage (SAH) regarding the association of selected variables and outcomes three months after the incident. 
Clinical reflections. The independent predicting factors of an unfavourable aneurysm SAH outcome are aneurysm re-rupture, 
high systolic blood pressure (SBP), and increased heart rate.
Clinical implications. The article findings confirm easily monitored parameters that could be potentially useful in clinical 
approaches to this critical illness.
(Neurol Neurochir Pol 2019; 53 (6): 398–399)
The increasingly common treatment of ruptured aneury-
sms with early and rapid endovascular procedures has signi-
ficantly affected the mortality of subarachnoid haemorrhage 
(SAH). However, this is still high and amounts to 40%. Moreo-
ver, about 30% of patients who survive the incident are severely 
disabled [1]. Therefore, to identify factors that are important 
for the prediction of aneurysm SAH outcomes is essential. 
Nastasovic et al. conducted a prospective study and revie-
wed the data from more than 250 consecutive subjects with 
this life-threatening condition [2]. They used the Glasgow 
Outcome Score (GOS) for SAH prognosis assessment. 
Aneurysm SAH is a complex disorder that involves damage 
to the central nervous system at different levels and multiple 
organ failure. Mortality in SAH is related to a substantial num-
ber of pathological conditions such as cerebral vasospasm (with 
secondary delayed cerebral ischaemia), recurrent subarachnoid 
haemorrhage (sometimes associated with intraventricular/
parenchymal bleeding), malignant intracranial hypertension, 
hydrocephalus, seizures, gastrointestinal bleeding, anaemia, 
neurogenic pulmonary oedema, cardiac complications, gluco-
se abnormalities, electrolytes imbalance (mostly low or high 
sodium levels), and thromboembolic events [3]. 
Clearly therefore, designing a reliable study that would 
cover all potential factors affecting prognosis in this critical 
illness is challenging. 
Numerous scientific reports have investigated SAH outcomes 
with regards to morphologic parameters of a ruptured aneurysm 
such as shape and flow angle, and especially its size [4]. Other 
studies have considered the clinical assessment of the initial neu-
rological condition of patients estimated using the Hunt and Hess, 
Fisher, or World Federation of Neurosurgical Societies (WFNS) 
rating scales [5]. Some articles have analysed the role of various 
biochemical parameters in aneurysm SAH outcome estimation [6]. 
The article by Nastasovic et al. is very interesting because 
the researchers explored various clinical, selected biochemical, 
and aneurysm-associated factors all together. They observed 
patients for three months, finally describing the independent 
predictive factors of an unfavourable aneurysm SAH outcome 
to be high systolic blood pressure (SBP), high heart rate on 
hospital admission, and aneurysm re-rupture.  
Intuitively, these parameters look familiar, especially given 
that premorbid hypertension is a well-recognised prognostic 
feature in this devastating disease. Only a few publications have 
pointed directly to the role of SBP measured at the beginning 
of hospitalisation in aneurysm SAH prognosis [7]. Recently, 
the SBP at admission and its variability were investigated in 
a clinical trial [8]. It is also very hard to find any article about 
heart rate as a factor critical to SAH outcome (estimated by 
GOS), and the revelation of this phenomenon by the team 
from Belgrade seems fundamental. 
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Over and above the methodological constraints and study 
limitations mentioned by the authors, the article might have 
a valuable impact on routine clinical practice, not only in terms 
of decision-making but also by informing patients and their 
relatives about the nature of this critical illness. It certainly 
helps them to arrange assistance, anticipate the quality of life, 
and plan the near future.
In summary, the findings of Nastasovic et al. suggest 
major potential approaches (with the elaboration of re-
levant neurocritical care protocols) regarding reducing 
aneurysm SAH complications to be aneurysm re-bleeding 
prevention and cardiovascular system support.  Hopefully 
in this way we can decrease aneurysm SAH mortality rates 
even more.
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